Want to see HK:0557 full AI Analyst Report?
0557 Stock Chart & Stats
HK$0.60
-HK$0.07(-10.45%)
At close: 4:00 PM EDT
HK$0.60
-HK$0.07(-10.45%)
Day’s Range― - ―
52-Week RangeHK$0.06 - HK$0.92
Previous CloseN/A
Volume374.00K
Average Volume (3M)666.00
Market Cap
HK$199.49M
Enterprise ValueHK$224.39
Total Cash (Recent Filing)HK$42.63M
Total Debt (Recent Filing)HK$37.46M
Price to Earnings (P/E)―
Beta-0.83
Next Earnings
Apr 01, 2027EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.07
Shares Outstanding398,979,520
10 Day Avg. Volume0
30 Day Avg. Volume666
Financial Highlights & Ratios
PEG Ratio14.08
Price to Book (P/B)1.73
Price to Sales (P/S)14.56
P/FCF Ratio30.63
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Manageable LeverageDebt-to-equity around 0.20–0.24 indicates a relatively conservative funding structure, reducing balance-sheet pressure compared with a highly leveraged model. This gives the company more financial flexibility to manage operations and pursue recovery while profitability remains weak.
Recent Cash GenerationPositive operating and free cash flow in 2023–2025, with 2025 free cash flow improving from 2024, provides an important source of internal funding. If maintained, this can support liquidity and reduce reliance on external capital despite reported losses.
Solid Gross MarginsGross margins remained above 50% in 2024–2025, showing that the business retains meaningful gross profit. This provides a base for future operating improvement, although overhead and other costs currently prevent that margin from becoming operating profit.
Bears Say
Revenue ContractionRevenue fell about 27% in 2025 and remains materially below 2021 levels, indicating sustained weakness in top-line momentum. Continued contraction can reduce scale benefits, limit reinvestment capacity, and make it harder to absorb fixed operating costs over the next several quarters.
Persistent Operating LossesEBIT and EBITDA have been negative across all reported periods, while net losses remain large and 2025 net margin was deeply negative. Persistent failure to convert gross profit into operating earnings weakens self-funded growth and raises the risk that cash generation will prove uneven.
Equity ErosionPersistent losses have pushed 2025 ROE to roughly -21% and reduced equity versus prior years, signaling ongoing erosion of shareholder capital. This weakens the balance-sheet cushion over time and can constrain strategic flexibility even though debt-to-equity remains moderate.
China Tian Yuan Healthcare Group Limited News
0557 FAQ
What was China Tian Yuan Healthcare Group Limited’s price range in the past 12 months?
China Tian Yuan Healthcare Group Limited lowest stock price was HK$0.06 and its highest was HK$0.92 in the past 12 months.
What is China Tian Yuan Healthcare Group Limited’s market cap?
China Tian Yuan Healthcare Group Limited’s market cap is HK$199.49M.
When is China Tian Yuan Healthcare Group Limited’s upcoming earnings report date?
China Tian Yuan Healthcare Group Limited’s upcoming earnings report date is Apr 01, 2027 which is in 181 days.
How were China Tian Yuan Healthcare Group Limited’s earnings last quarter?
China Tian Yuan Healthcare Group Limited released its earnings results on Aug 28, 2026. The company reported HK$0.01 earnings per share for the quarter.
Is China Tian Yuan Healthcare Group Limited overvalued?
According to Wall Street analysts China Tian Yuan Healthcare Group Limited’s price is currently Overvalued.
Does China Tian Yuan Healthcare Group Limited pay dividends?
China Tian Yuan Healthcare Group Limited does not currently pay dividends.
What is China Tian Yuan Healthcare Group Limited’s EPS estimate?
China Tian Yuan Healthcare Group Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does China Tian Yuan Healthcare Group Limited have?
China Tian Yuan Healthcare Group Limited has 398,979,520 shares outstanding.
What happened to China Tian Yuan Healthcare Group Limited’s price movement after its last earnings report?
China Tian Yuan Healthcare Group Limited reported an EPS of HK$0.01 in its last earnings report. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of China Tian Yuan Healthcare Group Limited?
Currently, no hedge funds are holding shares in HK:0557
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
China Tian Yuan Healthcare Group Limited
China Tian Yuan Healthcare Group Limited, an investment holding company, provides healthcare related services in Hong Kong, the People's Republic of China, and Korea. It operates through Investment Holding, Healthcare, Money Lending and Related Business, and Hospitality segments. The company offers procurement, marketing, and management services to the healthcare industry; and plastic surgery and medical beauty services, licenses trademarks, as well as optimal functionality for the properties; custom solutions, such as custom booking engines, website design and development, cutting-edge applications, and independent hotel management services. It also invests in equity investments; offers loans and related services; refers and introduces of lenders and borrowers; and provides procurement services to the hospitality industry. The company was formerly known as City e-Solutions Limited and changed its name to China Tian Yuan Healthcare Group Limited in November 2017. The company was incorporated in 1990 and is based in Wan Chai, Hong Kong. China Tian Yuan Healthcare Group Limited is a subsidiary of Tian Yuan Manganese Limited.
Technical Analysis
Keck Seng Investments (Hong Kong)
―
Langham Hospitality Investments
―
Magnificent Hotel Investments Limited
―
Sino Hotels (Holdings) Ltd.
―
Regal Hotels International Holdings Limited
―